# Oxytocin and Alcohol Withdrawal and Dependence

> **NCT02903251** · PHASE3 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 40 (actual)

## Conditions studied

- Alcoholism
- Substance-Related Disorders

## Interventions

- **DRUG:** intranasal oxytocin spray
- **OTHER:** intranasal spray without oxytocin

## Key facts

- **NCT ID:** NCT02903251
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-01-22
- **Final completion:** 2018-01-22
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903251, "Oxytocin and Alcohol Withdrawal and Dependence". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02903251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*